<?xml version="1.0" encoding="UTF-8"?>
<p>Some evidence associated high IL-6 levels with the severity and mortality of COVID-19 (
 <xref rid="B49" ref-type="bibr">49</xref>,
 <xref rid="B50" ref-type="bibr">50</xref>), although the levels of interferon (IFN)-Î³ tend to be somewhat decreased in severe cases compared with moderate cases. These cytokines are also increased in both the serum and bronchoalveolar lavage as well as in lung tissue from ARDS patients (
 <xref rid="B51" ref-type="bibr">51</xref>-
 <xref rid="B53" ref-type="bibr">53</xref>). This alteration in inflammatory response observed in COVID-19 patients could be associated with a reduction in CD4+, CD8+, and NK lymphocytes (
 <xref rid="B36" ref-type="bibr">36</xref>). In this regard, CD4+ T and CD8+ T were strongly reduced in patients with severe COVID-19 compared with those in patients with mild disease (
 <xref rid="B54" ref-type="bibr">54</xref>).
</p>
